4Filed Aug 31, 8:00 PM ET

NovaBridge (NBP) EVP Xu Cong Claire Exercises Options, Sells Shares

$NBP · NovaBridge Biosciences

Research Summary

AI-generated summary of this SEC filing

Updated

NovaBridge (NBP) EVP Xu Cong Claire Exercises Options, Sells Shares

What Happened

  • Xu Cong Claire, Executive Vice President, Clinical Development, exercised/conversion of derivatives on Aug 30, 2026, acquiring 9,382 ordinary shares (reported as 4,079 ADSs). The filing also shows a same‑day derivative disposition of 4,079 shares with $0 reported proceeds. On Aug 31, 2026 she sold 3,282 ordinary shares (reported as 1,427 ADSs) in an open‑market transaction at $0.79 per share for total proceeds of $2,593 (the converted ADS sales price reported was $1.8186 per ADS).
  • These moves include both an exercise/conversion of derivatives (M) and a small open‑market sale (S). Sales are often routine; the filing is factual about quantities and proceeds.

Key Details

  • Transaction dates & prices:
    • 2026-08-30: Exercise/conversion — 9,382 ordinary shares acquired (reported as 4,079 ADSs).
    • 2026-08-30: Derivative disposition — 4,079 shares reported disposed at $0.00 (derivative line).
    • 2026-08-31: Open‑market sale — 3,282 ordinary shares (1,427 ADSs) at $0.79 each; proceeds $2,593 (ADS‑converted price $1.8186).
  • Shares owned before/after (ADS basis, per filing footnotes): 133,688 ADSs before the transactions and 132,261 ADSs after the sale.
  • Notable footnotes:
    • ADS conversion: 10 ADSs = 23 ordinary shares (so filings report many amounts in ADS equivalents).
    • RSUs: Each RSU represents a contingent right to receive one ADS; a prior grant of 65,270 RSUs vests over four years (see footnote).
    • Reported sale price shown both in ordinary‑share and converted ADS terms.
  • Timeliness: Report filed 2026-09-01 for transactions through 2026-08-31 — filing appears timely (no late‑filing indicated).

Context

  • Derivative/exercise explanation: The Aug 30 entries are derivative exercises/conversions. A derivative disposition with $0 proceeds commonly reflects a net settlement or share delivery for withholding/tax purposes (the filing shows a zero‑proceeds derivative disposition separate from the open‑market sale).
  • For retail investors: purchases/exercises can indicate realization of option/RSU value; the small open‑market sale here generated modest proceeds ($2.6k) and should be viewed as routine insider activity rather than a major signal.